Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 4
Submit an article Journal homepage
1,371
Views
8
CrossRef citations to date
0
Altmetric
Neurology

Cognitive decline may not be adequately captured in economic evaluations of multiple sclerosis: are new treatments being undervalued?

Andrew Lloyda Acaster Lloyd Consulting Ltd, London, UKCorrespondence[email protected]
,
Helen Schofieldb Oxford PharmaGenesis, Oxford, UK
&
Nick Adlardc Novartis Pharma AG, Basel, Switzerland
Pages 609-611 | Received 09 Dec 2019, Accepted 14 Jan 2020, Published online: 04 Feb 2020

Figures & data

This paper does not have figures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.